EXPERIENCE OF RESPIRATORY FLUOROHINOLONUM LAEVOFLOXACINE APPLICATION («FLORACID®») IN PATIENTS WITH NON-SEVERE COMMUNITY-ACQUIRED PNEUMONIA

The dynamics of clinical and laboratory parameters in patients with community-acquired pneumonia were studied during the treatment with respiratory fluorohinolonum laevofloxacin «Floracid®». The high efficiency and safety of «Floracid®» were revealed during the research.

Bibliographic Details
Main Authors: A.P. Rebrov, E.Yu. Ponomarеva, I.A. Amirova
Format: Article
Language:Russian
Published: Saratov State Medical University 2007-09-01
Series:Саратовский научно-медицинский журнал
Subjects:
Online Access:http://www.ssmj.ru/system/files/200703_065.pdf